In melanoma, the BRAF V600E mutation is linked to increased STAT3 activity and increased expression of IL-1, IL-10, and IL-6, which in turn influence dendritic cell activity within the tumour microenvironment [87,94]. This evidence concerns the gene IL6 and neoplasm.